Category Archives: Legal

Sequestration: How Big a Hit for FDA, Research and Pharma?

The greatly feared federal budget sequestration mandate went into effect March 1, and, initially, the impact was fairly muted. The stock market soared, employment rose and government workers continued on their jobs. Federal agencies, including the Food and Drug Administration (FDA), launched initiatives to comply with the mandated 5% across-the-board cut in spending (in reality [...]
Also posted in FDA, R&D, healthcare, leadership | Tagged , , , , , , , | Leave a comment

Following Industry, OPDP Hopes to Eliminate Silos in Ad Review

The Office of Prescription Drug Promotion (OPDP) is reorganizing its two primary advertising review divisions – professional and consumer – in an attempt to stay in line with the silo-breaking, multi-channel promotional output pouring in from pharma. The line between physician marketing and consumer marketing has blurred as the facets of a brand campaign – from [...]
Also posted in Advertising, E-Media, FDA, Marketing, Patient Communication, Regulatory, Sales, compliance, patient education, social media | Tagged , , , | Leave a comment

Global Patent Management Made Easy

Patent Management Made Easy Even with a successfully launched start-up or spin-out to your name, you may still be tempted to close your eyes to the complexities of IP. But it’s actually very simple, writes Jason Rutt. So, you have done it. You have left big business or forsaken the dusty halls of academia to launch that [...]
Also posted in Europe, Global, Guest Blog, IP | Tagged , , , | Leave a comment

Daiichi Sankyo Faces Gender Discrimination Lawsuit

Six current and former female pharmaceutical sales representatives have filed a $100-million gender discrimination lawsuit against Daiichi Sankyo in a US district court. The company employs around 3000 people in the US. According to a statement from the law firm Sanford Heisler, which is representing the case, Daiichi Sankyo pays female sales reps less than male [...]
Also posted in Guest Blog | Tagged | Leave a comment

Getting it Done in Washington

During his fifth State of the Union address, President Obama struck many familiar chords – including a line about ending certain subsidies to pharmaceutical companies – and emphasized, repeatedly, the need to get things done on the policy front. Will the sequestration drum beat goad members of the 113th Congress onto the dance floor?
Also posted in R&D, Strategy, healthcare, pricing | Tagged , , , , , , , | Leave a comment